BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9616447)

  • 1. Opioid medication in the palliative care of motor neurone disease.
    Oliver D
    Palliat Med; 1998 Mar; 12(2):113-5. PubMed ID: 9616447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication in the last days of life for motor neuron disease/amyotrophic lateral sclerosis.
    Oliver DJ; Campbell C; O'brien T; Sloan R; Sykes N; Tallon C; Taylor-Horan J; Udoma M
    Amyotroph Lateral Scler; 2010 Dec; 11(6):562-4. PubMed ID: 20565331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life.
    Miura T; Matsumoto Y; Motonaga S; Hasuo H; Abe K; Kinoshita H
    Jpn J Clin Oncol; 2014 Nov; 44(11):1082-7. PubMed ID: 25249380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A regional survey of opioid use by patients receiving specialist palliative care.
    Brooks DJ; Gamble W; Ahmedzai S
    Palliat Med; 1995 Jul; 9(3):229-38. PubMed ID: 7582179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose ratios between high dose oral morphine or equivalents and oral methadone.
    Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
    J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use in dying patients in hospice and hospital, with and without specialist palliative care team involvement.
    Brown W
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):65-71. PubMed ID: 18181893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid switch in palliative care, opioid choice by clinical need and opioid availability.
    Müller-Busch HC; Lindena G; Tietze K; Woskanjan S
    Eur J Pain; 2005 Oct; 9(5):571-9. PubMed ID: 16139186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The care of the very old in the last three days of life.
    Rashidi NM; Zordan RD; Flynn E; Philip JA
    J Palliat Med; 2011 Dec; 14(12):1339-44. PubMed ID: 22145894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid use in palliative care of children and young people with cancer.
    Hewitt M; Goldman A; Collins GS; Childs M; Hain R
    J Pediatr; 2008 Jan; 152(1):39-44. PubMed ID: 18154896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmarking opioids in the last 24 hours of life.
    Ensor BR; Middlemiss TP
    Intern Med J; 2011 Feb; 41(2):179-85. PubMed ID: 20002858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commentary: a nursing perspective.
    Derby S
    J Pain Symptom Manage; 1998 Aug; 16(2):134. PubMed ID: 9737106
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliative Sedation at the End of Life: Patterns of Use in an Israeli Hospice.
    Azoulay D; Shahal-Gassner R; Yehezkel M; Eliyahu E; Weigert N; Ein-Mor E; Jacobs JM
    Am J Hosp Palliat Care; 2016 May; 33(4):369-73. PubMed ID: 25701661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of opioids in the last week of life in an acute palliative care unit.
    Mercadante S; Ferrera P; Casuccio A
    Am J Hosp Palliat Care; 2010 Dec; 27(8):514-7. PubMed ID: 20439486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor neurone disease: a hospice perspective.
    O'Brien T; Kelly M; Saunders C
    BMJ; 1992 Feb; 304(6825):471-3. PubMed ID: 1547416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
    Juba KM; Wahler RG; Daron SM
    J Palliat Med; 2013 Jul; 16(7):809-12. PubMed ID: 22925158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population.
    Good PD; Ravenscroft PJ; Cavenagh J
    Intern Med J; 2005 Sep; 35(9):512-7. PubMed ID: 16105151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative care for patients with motor neurone disease and their bereaved carers: a qualitative study.
    Mc Veigh C; Donaghy C; Mc Laughlin B; Dick A; Kaur K; Mc Conville J; Watson M
    BMC Palliat Care; 2019 Apr; 18(1):39. PubMed ID: 31027498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.